Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Strategies and technical challenges in allele level Class II typing in 2578 bone marrow transplantation donor-recipient pairs.

Williams TM, Winden T, Setterholm M, Vierra-Green CA, Spellman S, Flesch S, Awdeh Z, Baxter-Lowe LA, Begovich AB, Fernandez-Vina M, Hegland J, Hurley CK, Johnson D, Noreen H, Salazar M, Schmeckpeper B, Yunis EJ.

Hum Immunol. 2008 Apr-May;69(4-5):227-34. doi: 10.1016/j.humimm.2008.03.004. Epub 2008 Apr 25.

PMID:
18486756
2.

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, Hurley C, Kollman C, Anasetti C, Noreen H, Begovich A, Hildebrand W, Petersdorf E, Schmeckpeper B, Setterholm M, Trachtenberg E, Williams T, Yunis E, Weisdorf D.

Blood. 2004 Oct 1;104(7):1923-30. Epub 2004 Jun 10.

3.

New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans.

Klitz W, Maiers M, Spellman S, Baxter-Lowe LA, Schmeckpeper B, Williams TM, Fernandez-ViƱa M.

Tissue Antigens. 2003 Oct;62(4):296-307.

PMID:
12974796
4.

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes.

Nardin EH, Oliveira GA, Calvo-Calle JM, Castro ZR, Nussenzweig RS, Schmeckpeper B, Hall BF, Diggs C, Bodison S, Edelman R.

J Infect Dis. 2000 Nov;182(5):1486-96. Epub 2000 Oct 9.

PMID:
11023472
5.

The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairs.

Hurley CK, Baxter-Lowe LA, Begovich AB, Fernandez-Vina M, Noreen H, Schmeckpeper B, Awdeh Z, Chopek M, Salazar M, Williams TM, Yunis EJ, Kitajima D, Shipp K, Splett J, Winden T, Kollman C, Johnson D, Ng J, Hartzman RJ, Hegland J.

Bone Marrow Transplant. 2000 Feb;25(4):385-93.

6.

Large-scale DRB and DQB1 oligonucleotide typing for the NMDP registry: progress report from year 2.

Ng J, Hurley CK, Carter C, Baxter-Lowe LA, Bing D, Chopek M, Hegland J, Lee TD, Li TC, Hsu S, KuKuruga D, Mason JM, Monos D, Noreen H, Rosner G, Schmeckpeper B, Dupont B, Hartzman RJ.

Tissue Antigens. 1996 Jan;47(1):21-6.

PMID:
8929709
7.

Large-scale oligonucleotide typing for HLA-DRB1/3/4 and HLA-DQB1 is highly accurate, specific, and reliable.

Ng J, Hurley CK, Baxter-Lowe LA, Chopek M, Coppo PA, Hegland J, KuKuruga D, Monos D, Rosner G, Schmeckpeper B, et al.

Tissue Antigens. 1993 Nov;42(5):473-9.

PMID:
8146858
8.

High-resolution mapping of probes near the X-linked lymphoproliferative disease (XLP) locus.

Wu BL, Milunsky A, Nelson D, Schmeckpeper B, Porta G, Schlessinger D, Skare J.

Genomics. 1993 Jul;17(1):163-70.

PMID:
8406447
9.

Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment.

Wagner JE, Broxmeyer HE, Byrd RL, Zehnbauer B, Schmeckpeper B, Shah N, Griffin C, Emanuel PD, Zuckerman KS, Cooper S, et al.

Blood. 1992 Apr 1;79(7):1874-81.

Supplemental Content

Loading ...
Support Center